Excitatory amino acid antagonists and Parkinson's disease
- 31 August 1990
- journal article
- other
- Published by Elsevier in Trends in Neurosciences
- Vol. 13 (8), 325-326
- https://doi.org/10.1016/0166-2236(90)90140-6
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Excitatory amino acids and Parkinson's diseaseTrends in Neurosciences, 1990
- Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slicesNature, 1990
- Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's diseaseTrends in Neurosciences, 1989
- The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted miceJournal of Neural Transmission, 1989
- Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channelsEuropean Journal of Pharmacology, 1989
- Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in ratsPharmacology Biochemistry and Behavior, 1989
- Dopaminergic regulation of protein phosphorylation in the striatum: DARPP-32Trends in Neurosciences, 1987
- Anti-parkinsonian agents are phencyclidine agonists and N-methyl-aspartate antagonistsEuropean Journal of Pharmacology, 1987
- D 1 Dopamine Receptor Activation Required for Postsynaptic Expression of D 2 Agonist EffectsScience, 1987
- Characterization of the cholinergic stimulation of phosphoinositide hydrolysis in rat brain slicesJournal of Neuroscience, 1984